van der Geest, Lydia G M <br/><br/>
Survival in relation to hospital type after resection or sorafenib treatment for hepatocellular carcinoma in The Netherlands.  [electronic resource] 

 -  Clinics and research in hepatology and gastroenterology  Dec 2015 
 - 725-35 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2210-741X 
<br/><br/><label>Standard No.: </label>10.1016/j.clinre.2015.02.004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Agents--therapeutic use<br/>Carcinoma, Hepatocellular--mortality<br/>Cohort Studies<br/>Female<br/>Hepatectomy<br/>Hospitals--classification<br/>Humans<br/>Liver Neoplasms--mortality<br/>Male<br/>Middle Aged<br/>Netherlands<br/>Niacinamide--analogs & derivatives<br/>Phenylurea Compounds--therapeutic use<br/>Sorafenib<br/>Survival Rate